Agreed, Doc. As we approach the end of yet another
Post# of 36536
1). The time frames for IND submission given on the last conference call have come and gone. Where do we stand?
2). We were told the IPO would not be held up for any reason. Yet, despite Joe’s statements for over a year that we are close, we have no information on where we stand. DJ does not respond to calls (I have left 3 messages, not one returned call).
On JANUARY 12th, Joe stated he thought it would be “30-60 days to get this thing trading” (Great Wise Oz Show - ~49:30). If he can make a statement like that on an online stock show (this episode had 643 views yesterday when I re-watched it), why can’t there be information put out thru another means at this time? SIX months later, we are in the dark on the IPO.
3). Also on the last conference call, the Excellagen funding was touted as pretty much in the bag. Revenues are critical to avoid dilution and allow some upward share pricing pressure to build.
Yet we know NOTHING more after waiting over 2 months. Generex owes it to shareholders to inform us of progress or issues on this initiative.
Joe, we won’t wait forever. I personally have sold ~15% of my holdings. Without solid, measurable, concrete timelines on these initiatives, I and others will very soon move on to other opportunities, and there will be another downward spiral in your SP, further complicating your sole fundraising avenue.
We don’t need a conference call, in my opinion. Please either put out 3 detailed PRs to cover each of these topics or save the cash if you need to, and post information on the companies’ websites.